Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947996695> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2947996695 abstract "2546 Background: Early on-treatment changes in ctDNA may identify responders to immunotherapy and complement radiologic assessment of benefit. Here we investigate how early changes in ctDNA associate with long-term survival following treatment with immunotherapy, and if differential patterns in molecular ctDNA response (MCR) among patients with radiologic stable disease (SD) at first on-treatment scan could identify patients deriving benefit from treatment. Methods: Paired pre- and on-treatment (week 6-8) plasma samples from 3 cohorts of patients treated with durvalumab (D) +/- tremelimumab (D+T) were evaluated (NCT01693562, NCT02087423, NCT02261220). CtDNA was profiled with the 73-gene Guardant 360 assay. Nonsynonymous variants were summarized per patient to calculate variant allelic frequency changes (dVAF) and on-treatment variant allele frequency (pVAF). A combination of dVAF and pVAF was used to define MCR. Results: The reduction of ctDNA (dVAF<0) and undetectable on-treatment ctDNA (pVAF=0) were each associated with improved OS and PFS. An optimal threshold for MCR was determined from one cohort, then applied to the other cohorts. MCR associated with significantly improved PFS and OS across all three cohorts (Table). MCR was then applied to a pooled subgroup of patients with initial radiologic SD from all three cohorts (n=78). Patients with radiologic SD and MCR were significantly more likely than those without MCR to achieve radiologic CR or PR (pooled Odds ratio 12.7, p<0.001), had improved PFS (stratified pooled HR 0.36, p<0.001), and improved OS (stratified pooled HR 0.38, p=0.005). Conclusions: MCR is an early on-treatment tool that may identify patients with improved long-term survival and patients with radiologic SD who derive clinical benefit from immunotherapy. MCR may be a supportive endpoint in prospective clinical trials. MCR and survival benefit. [Table: see text]" @default.
- W2947996695 created "2019-06-07" @default.
- W2947996695 creator A5009504777 @default.
- W2947996695 creator A5020874666 @default.
- W2947996695 creator A5022984824 @default.
- W2947996695 creator A5026826195 @default.
- W2947996695 creator A5029805571 @default.
- W2947996695 creator A5051699207 @default.
- W2947996695 creator A5062202820 @default.
- W2947996695 creator A5090385143 @default.
- W2947996695 date "2019-05-20" @default.
- W2947996695 modified "2023-09-27" @default.
- W2947996695 title "Molecular circulating tumor DNA response to identify long-term survival in patients receiving immunotherapy with initial radiologic stable disease." @default.
- W2947996695 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.2546" @default.
- W2947996695 hasPublicationYear "2019" @default.
- W2947996695 type Work @default.
- W2947996695 sameAs 2947996695 @default.
- W2947996695 citedByCount "0" @default.
- W2947996695 crossrefType "journal-article" @default.
- W2947996695 hasAuthorship W2947996695A5009504777 @default.
- W2947996695 hasAuthorship W2947996695A5020874666 @default.
- W2947996695 hasAuthorship W2947996695A5022984824 @default.
- W2947996695 hasAuthorship W2947996695A5026826195 @default.
- W2947996695 hasAuthorship W2947996695A5029805571 @default.
- W2947996695 hasAuthorship W2947996695A5051699207 @default.
- W2947996695 hasAuthorship W2947996695A5062202820 @default.
- W2947996695 hasAuthorship W2947996695A5090385143 @default.
- W2947996695 hasConcept C121608353 @default.
- W2947996695 hasConcept C126322002 @default.
- W2947996695 hasConcept C142724271 @default.
- W2947996695 hasConcept C143998085 @default.
- W2947996695 hasConcept C203014093 @default.
- W2947996695 hasConcept C2777701055 @default.
- W2947996695 hasConcept C2779134260 @default.
- W2947996695 hasConcept C2781335228 @default.
- W2947996695 hasConcept C502942594 @default.
- W2947996695 hasConcept C71924100 @default.
- W2947996695 hasConceptScore W2947996695C121608353 @default.
- W2947996695 hasConceptScore W2947996695C126322002 @default.
- W2947996695 hasConceptScore W2947996695C142724271 @default.
- W2947996695 hasConceptScore W2947996695C143998085 @default.
- W2947996695 hasConceptScore W2947996695C203014093 @default.
- W2947996695 hasConceptScore W2947996695C2777701055 @default.
- W2947996695 hasConceptScore W2947996695C2779134260 @default.
- W2947996695 hasConceptScore W2947996695C2781335228 @default.
- W2947996695 hasConceptScore W2947996695C502942594 @default.
- W2947996695 hasConceptScore W2947996695C71924100 @default.
- W2947996695 hasLocation W29479966951 @default.
- W2947996695 hasOpenAccess W2947996695 @default.
- W2947996695 hasPrimaryLocation W29479966951 @default.
- W2947996695 hasRelatedWork W2588078993 @default.
- W2947996695 hasRelatedWork W2607977201 @default.
- W2947996695 hasRelatedWork W2783576981 @default.
- W2947996695 hasRelatedWork W2789072552 @default.
- W2947996695 hasRelatedWork W2892086764 @default.
- W2947996695 hasRelatedWork W2898037973 @default.
- W2947996695 hasRelatedWork W2906713843 @default.
- W2947996695 hasRelatedWork W2944921259 @default.
- W2947996695 hasRelatedWork W3000167079 @default.
- W2947996695 hasRelatedWork W3005467221 @default.
- W2947996695 hasRelatedWork W3013941234 @default.
- W2947996695 hasRelatedWork W3015125425 @default.
- W2947996695 hasRelatedWork W3030855893 @default.
- W2947996695 hasRelatedWork W3034262047 @default.
- W2947996695 hasRelatedWork W3096081681 @default.
- W2947996695 hasRelatedWork W3097357356 @default.
- W2947996695 hasRelatedWork W3131208308 @default.
- W2947996695 hasRelatedWork W3172883588 @default.
- W2947996695 hasRelatedWork W3211951539 @default.
- W2947996695 hasRelatedWork W3213749171 @default.
- W2947996695 isParatext "false" @default.
- W2947996695 isRetracted "false" @default.
- W2947996695 magId "2947996695" @default.
- W2947996695 workType "article" @default.